Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2026-03-01 @ 4:46 PM
Study NCT ID:
NCT02585934
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2015-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
Sponsor:
Axovant Sciences Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-22
First Submit QC Date:
None
Study First Post Date:
2015-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-30
Results First Submit QC Date:
None
Results First Post Date:
2018-12-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-08
Last Update Post Date:
2018-12-05
Last Update Post Date Type:
ACTUAL